Key result
Gut microbiota dysbiosis and associated metabolites contribute to inflammation and endothelial dysfunction, facilitating the onset of cardiovascular diseases such as atherosclerosis and heart failure.
Why the study?
Even when traditional risk factors are treated to target, residual cardiovascular disease risk remains, prompting review of the gut microbiota as a potential contributor and therapeutic target.
Systematic Review
This review highlights the emerging role of gut microbiota dysbiosis in cardiovascular disease pathogenesis and identifies microbiome modulation as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Gut microbiota may contribute to residual CV risk; leaves open whether dysbiosis-targeted interventions improve outcomes.
INTRODUCTION: The pathophysiology of cardiovascular diseases encompasses a complex interplay of genetic and environmental risk factors. Even if traditional risk factors are treated to target, there remains a residual risk. AREAS COVERED: This manuscript reviews the potential role of gut microbiota in the development of cardiovascular disease, and as potential target. A systematic search was conducted until 30 October 2024 on PubMed (MEDLINE), using the MeSH terms [Gut microbiota] + [Dysbiosis] + [Cardiovascular] + [TMAO] + [bile acids] + [short-chain fatty acids]. EXPERT OPINION: The term dysbiosis implies changes in equilibrium, with modifications in the composition and functionality of microbiota and a series of additional factors: reduced diversity and uniformity of microorganisms; reduced short-chain fatty acid-producing bacteria; increased gut permeability; release of metabolites, such as trimethylamine N-oxide, betaine, phenylalanine, tryptophan-kynurenine, phenylacetylglutamine, and lipopolysaccharides; and reduced secondary bile acid excretion, leading to inflammation, oxidative stress, and endothelial dysfunction and facilitating the onset of pathological conditions, including obesity, hypertension, diabetes, atherosclerosis, and heart failure. Attempts to restore gut microbiota balance through different interventions, mainly changes in diet, have been shown to positively affect individual components and metabolites and reduce the risk of cardiovascular disease. In addition, probiotics and prebiotics are potentially useful. Fecal microbiota transplantation is a promising therapy.
No takes yet. Share an insight, caveat, or question.
Escobar et al. (2025) conducted a systematic review in Cardiovascular disease. Gut microbiota dysbiosis was evaluated. Gut microbiota dysbiosis and associated metabolites contribute to inflammation and endothelial dysfunction, facilitating the onset of cardiovascular diseases such as atherosclerosis and heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: